A multicentre longitudinal observational study of changes in self reported health status in people with Parkinson's disease left untreated at diagnosis.
about
Treatment disparities in Parkinson's disease.Controversies in neurology: why monoamine oxidase B inhibitors could be a good choice for the initial treatment of Parkinson's disease.Improving symptom control in early Parkinson's diseasePatient considerations in early management of Parkinson's disease: focus on extended-release pramipexoleNonmotor symptoms in Parkinson's disease in 2012: relevant clinical aspects.Symptoms and quality of life in late stage Parkinson syndromes: a longitudinal community study of predictive factorsDysautonomia Differentially Influences the Effect of Affective Pain Perception on Quality of Life in Parkinson's Disease PatientsClinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with (123I) ioflupane in diagnosis of parkinsonian syndromes.The KMDS-NATION Study: Korean Movement Disorders Society Multicenter Assessment of Non-Motor Symptoms and Quality of Life in Parkinson's Disease NATION Study GroupSpecific patient-reported outcome measures for Parkinson's disease: analysis and applications.How should we treat a patient with early Parkinson's disease?Parkinson's disease--the continuing search for biomarkers.Should treatment for Parkinson's disease start immediately on diagnosis or delayed until functional disability develops?Emerging analgesic drugs for Parkinson's disease.Treatment in early Parkinson's disease: the Norwegian ParkWest study.Early versus delayed initiation of pharmacotherapy in Parkinson's disease.Modern treatment in Parkinson's disease, a personal approach.Nonmotor symptoms in a malaysian Parkinson's disease population.Clinical utility of DaTscan™ imaging in the evaluation of patients with parkinsonism: a US perspective.Knowledge of Parkinson's Disease in a Multiethnic Urban Asian Setting.Established therapies and novel targets in the treatment of Parkinson's disease.Self-reported health in people with Parkinson's disease left untreated at diagnosis.Health-related quality of life in Parkinson's disease patients in northeastern Sicily, Italy: (An ecological perspective).Are delayed-start design trials to show neuroprotection in Parkinson's disease fundamentally flawed?Health-related quality of life among community-dwelling patients with intractable neurological diseases and their caregivers in Japan.Health-related quality of life in Asian and other ethnic groups with Parkinson's disease.Impact of 6-month earlier versus postponed initiation of rotigotine on long-term outcome: post hoc analysis of patients with early Parkinson's disease with mild symptom severity.
P2860
Q33796430-D5689014-50DB-4200-AEAF-39245C64BEE5Q34027880-7DBEBF33-749E-40C3-B341-DA470E3B8CDAQ34409267-02601EC4-F92E-489E-8209-3BB6CC8D8BB5Q35716858-FF2BE446-2243-40D5-97BC-B7C56FFB0E4DQ36135045-CC90F5B3-686D-4250-88AA-4600FD3810CCQ36380930-6ED691F8-557B-443B-BBA9-07B4FCBEB93FQ36894179-5CD71608-60CB-47EB-873A-892037675E5EQ37267591-F39D6B1A-1DD8-4F75-865A-E214FE80B847Q37338662-9573A361-EAF9-492C-B8D8-5868DFBE56EDQ37763129-394F3E37-A9E8-42C2-9830-A53FAAA8BB95Q37775098-2F4871FF-6AE1-4A8A-AB65-FC38EF7C4D6AQ37834648-C2D17374-4BFF-4B06-AC93-680E61C9DEABQ37865446-42974F9A-0068-4D48-AA7C-5B3E71DE3572Q38005224-66FE119C-8CCD-444B-8358-56C0BD41E5F6Q38063341-A3EE677F-AC14-4279-922D-8477383C55D0Q38206403-D3D269D8-E276-43CE-B7BD-9A574A2F1E2FQ38570529-081B3219-A312-4551-ADE9-1CCF6ED26016Q38886519-A277B9C8-F7C4-4440-846F-BC230EAAE402Q38998616-E308E3A4-B8DF-42A4-A252-6CC79F06BE32Q40320324-ABE727CB-2DD8-4CD7-B3B1-EAA47D946055Q42723595-24266339-73BB-42A9-8BC1-0D1E7D29E4EEQ42766070-13578BC2-F5DE-4E51-BD9C-F1EAE75FAEE4Q42844633-6BCD6E54-18ED-4085-8014-FADD92689909Q46823146-D82A57BB-8D5E-45CC-A1EC-A88B6CDA5690Q48747132-CC446F4D-1423-4E5D-8E44-2E34AB248BC5Q53140510-1240854B-E269-418A-9AA7-B481A4979A2FQ53496951-9C3314D5-6E14-464E-9A07-F1DB3314E6D6
P2860
A multicentre longitudinal observational study of changes in self reported health status in people with Parkinson's disease left untreated at diagnosis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
A multicentre longitudinal obs ...... e left untreated at diagnosis.
@ast
A multicentre longitudinal obs ...... e left untreated at diagnosis.
@en
type
label
A multicentre longitudinal obs ...... e left untreated at diagnosis.
@ast
A multicentre longitudinal obs ...... e left untreated at diagnosis.
@en
prefLabel
A multicentre longitudinal obs ...... e left untreated at diagnosis.
@ast
A multicentre longitudinal obs ...... e left untreated at diagnosis.
@en
P2093
P2860
P356
P1476
A multicentre longitudinal obs ...... se left untreated at diagnosis
@en
P2093
A Williams
B Castleton
D MacMahon
P2860
P304
P356
10.1136/JNNP.2006.098327
P407
P577
2006-11-10T00:00:00Z